Sanofi Loses Bid To End Taxotere Eye Injury MDL Claims On Preemption Grounds
NEW ORLEANS — The manufacturer of a chemotherapy drug that allegedly caused eye injuries had “newly acquired information” about the risk and could have changed its label under the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article